The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
<p>Abstract</p> <p>Background</p> <p>A large phase III placebo-controlled, randomized efficacy trial of an investigational 11-valent pneumococcal conjugate vaccine against pneumonia in children less than 2 years of age was conducted in the Philippines from July 2000 to...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-06-01
|
| Series: | BMC Research Notes |
| Online Access: | http://www.biomedcentral.com/1756-0500/5/274 |
| _version_ | 1818379249696899072 |
|---|---|
| author | Sanvictores Diozele Hazel M Lucero Marilla G Nohynek Hanna Tallo Veronica L Tanskanen Antti Nillos Leilani T Williams Gail |
| author_facet | Sanvictores Diozele Hazel M Lucero Marilla G Nohynek Hanna Tallo Veronica L Tanskanen Antti Nillos Leilani T Williams Gail |
| author_sort | Sanvictores Diozele Hazel M |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>A large phase III placebo-controlled, randomized efficacy trial of an investigational 11-valent pneumococcal conjugate vaccine against pneumonia in children less than 2 years of age was conducted in the Philippines from July 2000 to December 2004. Clinical data from 12,194 children who were given either study vaccine or placebo was collected from birth up to two years of age for the occurrence of radiologically proven pneumonia as the primary endpoint, and for clinical pneumonia and invasive pneumococcal disease as the secondary endpoints. Several tertiary endpoints were also explored. Along the core trial, several satellite studies on herd immunity, cost-effectiveness of the study vaccine, acute otitis media, and wheezing were conducted.</p> <p>Results</p> <p>We describe here in detail how the relevant clinical records were managed and how quality control procedures were implemented to ensure that valid data were obtained respectively for the core trial and for the satellite studies. We discuss how the task was achieved, what the challenges were and what might have been done differently.</p> <p>Conclusions</p> <p>There were several factors that made the task of data management doable and efficient. First, a pre-trial data management system was available. Secondly, local committed statisticians, programmers and support staff were available and partly familiar to clinical trials. Thirdly, the personnel had undergone training during trial and grew with the task they were supposed to do. Thus the knowledge needed to develop and operate clinical data system was fully transferred to local staff.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN62323832</p> |
| first_indexed | 2024-12-14T01:59:47Z |
| format | Article |
| id | doaj.art-948b9be588dd41a2b2649bc594f4b789 |
| institution | Directory Open Access Journal |
| issn | 1756-0500 |
| language | English |
| last_indexed | 2024-12-14T01:59:47Z |
| publishDate | 2012-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Research Notes |
| spelling | doaj.art-948b9be588dd41a2b2649bc594f4b7892022-12-21T23:21:03ZengBMCBMC Research Notes1756-05002012-06-015127410.1186/1756-0500-5-274The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the PhilippinesSanvictores Diozele Hazel MLucero Marilla GNohynek HannaTallo Veronica LTanskanen AnttiNillos Leilani TWilliams Gail<p>Abstract</p> <p>Background</p> <p>A large phase III placebo-controlled, randomized efficacy trial of an investigational 11-valent pneumococcal conjugate vaccine against pneumonia in children less than 2 years of age was conducted in the Philippines from July 2000 to December 2004. Clinical data from 12,194 children who were given either study vaccine or placebo was collected from birth up to two years of age for the occurrence of radiologically proven pneumonia as the primary endpoint, and for clinical pneumonia and invasive pneumococcal disease as the secondary endpoints. Several tertiary endpoints were also explored. Along the core trial, several satellite studies on herd immunity, cost-effectiveness of the study vaccine, acute otitis media, and wheezing were conducted.</p> <p>Results</p> <p>We describe here in detail how the relevant clinical records were managed and how quality control procedures were implemented to ensure that valid data were obtained respectively for the core trial and for the satellite studies. We discuss how the task was achieved, what the challenges were and what might have been done differently.</p> <p>Conclusions</p> <p>There were several factors that made the task of data management doable and efficient. First, a pre-trial data management system was available. Secondly, local committed statisticians, programmers and support staff were available and partly familiar to clinical trials. Thirdly, the personnel had undergone training during trial and grew with the task they were supposed to do. Thus the knowledge needed to develop and operate clinical data system was fully transferred to local staff.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN62323832</p>http://www.biomedcentral.com/1756-0500/5/274 |
| spellingShingle | Sanvictores Diozele Hazel M Lucero Marilla G Nohynek Hanna Tallo Veronica L Tanskanen Antti Nillos Leilani T Williams Gail The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines BMC Research Notes |
| title | The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines |
| title_full | The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines |
| title_fullStr | The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines |
| title_full_unstemmed | The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines |
| title_short | The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines |
| title_sort | data management of a phase iii efficacy trial of an 11 valent pneumococcal conjugate vaccine and related satellite studies conducted in the philippines |
| url | http://www.biomedcentral.com/1756-0500/5/274 |
| work_keys_str_mv | AT sanvictoresdiozelehazelm thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT luceromarillag thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT nohynekhanna thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT talloveronical thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT tanskanenantti thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT nillosleilanit thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT williamsgail thedatamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT sanvictoresdiozelehazelm datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT luceromarillag datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT nohynekhanna datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT talloveronical datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT tanskanenantti datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT nillosleilanit datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines AT williamsgail datamanagementofaphaseiiiefficacytrialofan11valentpneumococcalconjugatevaccineandrelatedsatellitestudiesconductedinthephilippines |